| Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19 T Islam, MR Rahman, B Aydin, H Beklen, KY Arga, M Shahjaman European Journal of Pharmacology 887, 173594, 2020 | 64 | 2020 |
| Pan-cancer mapping of differential protein-protein interactions G Gulfidan, B Turanli, H Beklen, R Sinha, KY Arga Scientific reports 10 (1), 3272, 2020 | 49 | 2020 |
| Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks G Gulfidan, M Soylu, D Demirel, HBC Erdonmez, H Beklen, PO Sarica, ... Archives of biochemistry and biophysics 715, 109085, 2022 | 25 | 2022 |
| Drug repositioning for P-glycoprotein mediated co-expression networks in colorectal cancer H Beklen, G Gulfidan, KY Arga, A Mardinoglu, B Turanli Frontiers in oncology 10, 1273, 2020 | 21 | 2020 |
| Higher proteotoxic stress rather than mitochondrial damage is involved in higher neurotoxicity of bortezomib compared to carfilzomib AT Jannuzzi, S Arslan, AM Yilmaz, G Sari, H Beklen, L Méndez, ... Redox biology 32, 101502, 2020 | 20 | 2020 |
| Artificial intelligence as accelerator for genomic medicine and planetary health G Gulfidan, H Beklen, KY Arga OMICS: A Journal of Integrative Biology 25 (12), 745-749, 2021 | 13 | 2021 |
| Laparoscopic liver resection for colorectal liver metastases—short-and long-term outcomes: A systematic review E Taillieu, C De Meyere, F Nuytens, C Verslype, M D'Hondt World Journal of Gastrointestinal Oncology 13 (7), 732, 2021 | 12 | 2021 |
| The repertoire of glycan alterations and glycoproteins in human cancers M Kori, B Aydin, G Gulfidan, H Beklen, N Kelesoglu, A Caliskan Iscan, ... OMICS: A Journal of Integrative Biology 25 (3), 139-168, 2021 | 8 | 2021 |
| Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors B Aydin, H Beklen, KY Arga, F Bayrakli, B Turanli Journal of Endocrinological Investigation 46 (4), 727-747, 2023 | 6 | 2023 |
| Differential interactome based drug repositioning unraveled abacavir, exemestane, nortriptyline hydrochloride, and tolcapone as potential therapeutics for colorectal cancers H Beklen, S Arslan, G Gulfidan, B Turanli, P Ozbek, B Karademir Yilmaz, ... Frontiers in Bioinformatics 1, 710591, 2021 | 6 | 2021 |
| Systems-level biomarkers identification and drug repositioning in colorectal cancer H Beklen, E Yildirim, M Kori, B Turanli, KY Arga World Journal of Gastrointestinal Oncology 13 (7), 638, 2021 | 5 | 2021 |
| Differential protein interactome in esophageal squamous cell carcinoma offers novel systems biomarker candidates with high diagnostic and prognostic performance G Gulfidan, H Beklen, I Sinha, F Kucukalp, B Caloglu, I Esen, B Turanli, ... OMICS: A Journal of Integrative Biology 25 (8), 495-512, 2021 | 2 | 2021 |
| ANALYSIS OF DIFFERENTIAL INTERACTOME IN COLORECTAL ADENOCARCINOMA TO IDENTIFY CANDIDATE BIOMARKERS AND THERAPEUTICS H BEKLEN MARMARA UNIVERSITY, 2021 | | 2021 |
